Investing

Jasper Therapeutics : JSPR

JSPR

Stock Data

$0.93

$0.01 (0.61%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Jasper Therapeutics Inc is a biotech firm based in Redwood City, California, focusing on innovative treatments in the realm of stem cell transplantation and gene therapies. It's at the forefront with its lead product, briquilimab, aimed at preparing patients for stem cell or gene therapy by clearing hematopoietic stem cells from the bone marrow. Additionally, Jasper is pioneering in developing engineered stem cells to enhance the effectiveness of both allogeneic and autologous gene-edited stem cell grafts, targeting a range of diseases including chronic spontaneous urticaria and myelodysplastic syndrome.

All Jasper Therapeutics Articles

1 Article

Lee Jackson | Mar 23, 2026 at 7:08 AM EDT

Here Are Monday’s Top Wall Street Analyst Research Calls: APA Corporation, Cheniere Energy, Crown Castle, Hut 8, MongoDB, Red Rock Resorts, Super Micro Computer, Terawulf, and More

Pre-Market Stock Futures: Futures are trading higher after President Trump signalled that talks with Iran are progressing positively, as we…